Improve operations.
Expand capabilities.
Trusted in 10 commercial cell therapies* and over 150 clinical trials**, the CliniMACS Plus Instrument has set the benchmark for clinical cell enrichment and depletion across 17 immune cell types. Now, we take proven excellence further, transforming your workflow with enhanced capabilities, improved user experience, and full GMP compliance.
*Approved substantially manipulated cell therapies and gene-modified cell therapies in Europe, USA and China.
**Active clinical trials, hospital treatments, or commercial treatments using CliniMACS Plus for manufacturing of cell products.
Improve operations.
Expand capabilities.
Ready for today and tomorrow
New hardware capabilities meet your pipeline where it is now – and where it's going. Whether you're developing autologous or allogeneic therapies, CAR T, CAR NK, or the next generation of stem cell grafts, the platform is architected to grow with your ambitions.
Your protocols, new instrument
Validated applications transfer seamlessly to the new instrument – your existing work is protected. Optional customization services let you tailor workflows to your exact needs. No rebuilding from scratch. No re-qualification from zero.
GMP compliant from day one
Our 21 CFR Part 11-compliant software with comprehensive audit trails and secure data transfer ensures you're regulatory-ready from the start. Robust network connectivity integrates into your existing IT infrastructure, supporting smooth inspections and faster approval timelines.
We're with you every step of the way
From customized application support and tailored training programs to service packages that maximize uptime – we keep you compliant and focused on what matters: advancing therapies.
Technical snapshot
Seamless transition. Zero disruption.
Built on the same trusted platform, the new CliniMACS Plus Instrument is designed to protect your existing work – whether you're mid-clinical trial or at commercial scale.
Your validated protocols come with you.
Coming soon – the new CliniMACS Plus Instrument
Sign up for our clinical newsletters (cell & gene therapy) so you don't miss release updates and additional information.
Do you need more information? Connect with us today.
*Approved substantially manipulated cell therapies and gene-modified cell therapies in Europe, USA and China.
**Active clinical trials, hospital treatments, or commercial treatments using CliniMACS Plus for manufacturing of cell products.
You have previously chosen International as your location.
What do you want to do?